Top Markets
#1 Siren Siren +30.45%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +26.06%
#3 OriginTrail OriginTrail +21.43%
#4 DogBull DogBull +14.01%
#5 MarsCoin MarsCoin +12.76%
#6 COTI COTI +9.75%
#7 Xphere Xphere +6.05%
#8 Concordium Concordium +6.00%
#9 PulseChain PulseChain +5.89%
#10 Pons Pons +5.77%
Coin of the day
Siren Siren
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
3D Global Biotech Inc. 3D Global Biotech Inc.

3D Global Biotech Inc.

6808
Kedudukan dalam Saham #22396
Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in... Based in New Taipei City, China, 3D Global Biotech Inc. (3DGBI) specializes in the development of advanced medical materials designed for human body reconstruction. The company leverages sophisticated cell culture systems, cutting-edge 3D printing technology, and proprietary bio-inks hydrogel to create personalized, patient-specific cell-based medical products. Beyond product manufacturing, 3DGBI is dedicated to building platforms for human tissue and organ regeneration, engineering customized medical equipment, and undertaking significant professional research. Its extensive product range includes artificial bone substitutes, skull fixation systems, biological dressings, bio-inks, and bioprinting machinery. They also offer specialized solutions for orthopedic, dental, cranial, and scalp reconstruction. The company serves a broad spectrum of clients, including medical centers, research institutions, businesses, and distributors. 3DGBI actively fosters an interdisciplinary alliance, bringing together expertise from industry, government, academia, research, and medicine. It was established in 2014.
Harga Saham
$1.16
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$89.35M
Perubahan (1 hari)
-1.22%
Perubahan (1 tahun)
-15.74%
Negara
TW
Perdagangan 3D Global Biotech Inc. (6808)

Kategori

Healthcare
Nisbah P/E bagi 3D Global Biotech Inc. (6808)
Nisbah P/E pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini 3D Global Biotech Inc., nisbah P/E semasa (TTM) ialah 0. Pada akhir 2026, syarikat mempunyai nisbah P/E sebanyak 0.
Sejarah nisbah P/E bagi 3D Global Biotech Inc. dari 2026 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.